Comparative Genomic Hybridization (CGH) using metaphase chromosome spreads to screen all human chromosomes for aneuploidy in preimplantation embryos is hindered by the time required to perform the analysis. DNA microarrays manufactured to date are not able to analyze the very limited amount of genetic material in a single cell. We have developed a DNA Microarray-Comparative Genomic Hybrydization (CGH) approach, which is capable of screening all 24 human chromosomes for aneuploidy and sex chromosomal abnormalities in a single cell. This technique has a number of applications including aneuploidy detection in single fetal cells isolated noninvasively from pregnant women for prenatal diagnosis. In this chapter, we describe in detail the method...
One of the most important factors influencing embryo viability is chromosome imbalance (aneuploidy)....
One of the most important factors influencing embryo viability is chromosome imbalance (aneuploidy)....
Miscarriage is a condition that affects 10%–15% of all clinically recognized pregnancies, most of wh...
The use of metaphase comparative genomic hybridization (CGH) to screen all human chromosomes for ane...
© European Society of Human Reproduction and EmbryologyThe use of metaphase comparative genomic hybr...
Genomic imbalances are a major cause of constitu-tional and acquired disorders. Therefore, aneuploid...
Comprehensive chromosome analysis techniques such as metaphase-Comparative Genomic Hybridisation (CG...
Altres ajuts: Predoctoral grant from the Universitat Autònoma de BarcelonaComprehensive chromosome a...
Cytogenetic analysis is a crucial tool of prenatal diagnosis. The ability to rapidly detect aneuploi...
Microarray-based comparative genomic hybridization (array CGH) is a newly emerged molecular cytogene...
Cytogenetic analysis is a crucial tool of prenatal diagnosis. The ability to rapidly detect aneuploi...
Abstract Background While conventional G-banded karyotyping still remains a gold standard in prenata...
Abstract: At least 50 % of human embryos are abnormal, and that increases to 80 % in women 40 years ...
OBJECTIVE: To validate and determine the best array-comparative genomic hybridization (aCGH; array-C...
Numerical chromosome errors are known to be common in early human embryos and probably make a signif...
One of the most important factors influencing embryo viability is chromosome imbalance (aneuploidy)....
One of the most important factors influencing embryo viability is chromosome imbalance (aneuploidy)....
Miscarriage is a condition that affects 10%–15% of all clinically recognized pregnancies, most of wh...
The use of metaphase comparative genomic hybridization (CGH) to screen all human chromosomes for ane...
© European Society of Human Reproduction and EmbryologyThe use of metaphase comparative genomic hybr...
Genomic imbalances are a major cause of constitu-tional and acquired disorders. Therefore, aneuploid...
Comprehensive chromosome analysis techniques such as metaphase-Comparative Genomic Hybridisation (CG...
Altres ajuts: Predoctoral grant from the Universitat Autònoma de BarcelonaComprehensive chromosome a...
Cytogenetic analysis is a crucial tool of prenatal diagnosis. The ability to rapidly detect aneuploi...
Microarray-based comparative genomic hybridization (array CGH) is a newly emerged molecular cytogene...
Cytogenetic analysis is a crucial tool of prenatal diagnosis. The ability to rapidly detect aneuploi...
Abstract Background While conventional G-banded karyotyping still remains a gold standard in prenata...
Abstract: At least 50 % of human embryos are abnormal, and that increases to 80 % in women 40 years ...
OBJECTIVE: To validate and determine the best array-comparative genomic hybridization (aCGH; array-C...
Numerical chromosome errors are known to be common in early human embryos and probably make a signif...
One of the most important factors influencing embryo viability is chromosome imbalance (aneuploidy)....
One of the most important factors influencing embryo viability is chromosome imbalance (aneuploidy)....
Miscarriage is a condition that affects 10%–15% of all clinically recognized pregnancies, most of wh...